Blood test screening for lung cancer spread
Part of Cancer, Lungs & breathing clinical trials.
This trial uses a special blood test to find molecules that may show if lung cancer has spread through the bloodstream. The goal is to help doctors detect metastasis earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with lung cancer that has spread to other parts of the body (hematogenous metastasis).
- You are willing to take part in the study and follow the instructions.
- You or your legal representative can sign a consent form agreeing to the study.
- You do not have any other type of cancer.
- You do not have severe lung diseases like bronchiectasis, asthma, or COPD, and you have not had long-term exposure to dust, mines, or asbestos.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is evaluating a blood-based test that might detect lung cancer early, before symptoms appear. Researchers are looking for heavy smokers who have no signs of cancer, as well as those with suspicious lung nodules or confirmed lung cancer, to see if a simple blood draw could help identify cancer sooner.
This study uses a special blood test to see if lung nodules are benign or malignant. It aims to improve early detection of lung cancer without invasive procedures.
This study uses a new blood test to detect lung cancer in people with lung nodules found on CT scans. The test looks for unique patterns in your blood that may help tell if a nodule is cancerous.
This study uses a blood test to look for tiny genetic markers (miRNA and DNA methylation) that may help detect lung cancer early. If you have a lung nodule or mass found on a CT scan and haven't had treatment yet, you may be able to join.
This trial uses a special blood test to detect lung cancer types. It may help doctors identify the specific type of lung cancer you have without invasive procedures.
This trial studies if a blood test that looks for tumor DNA combined with a PET-CT scan can better predict if lung cancer has spread to lymph nodes. It may help guide treatment decisions for people with non-small cell lung cancer that hasn't been treated yet.
Hear when a new Lung Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.